Biomedical subjects

R Ilic

Publications and source records attributed to R Ilic.

4 recordsLinked to original sources

PubMed2005

Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.

Tumour cell destruction in boron neutron-capture therapy (BNCT) is due to the nuclear reaction between (10)B and thermal neutrons. It is necessary for effective BNCT therapy to accumulate (10)B atoms in the tumour cells. The delivery system consisted of polyethylene-glycol (PEG) binding liposomes (DPPC/cholesterol/DSPC-PEG2000) with an entrapped (10)B-compound and we evaluated the cytotoxic effects of intravenously injected (10)B-PEG-liposomes on human pancreatic carcinoma xenografts in nude mice with thermal neutron irradiation. After thermal neutron irradiation of mice injected with (10)B-PEG-liposomes, growth of AsPC-1 tumours was suppressed relative to controls. Injection of (10)B-PEG-liposomes caused the greatest tumour suppression with thermal neutron irradiation in vivo. These results suggest that intravenous injection of (10)B-PEG-liposomes can increase the retention of (10)B atoms by tumour cells, causing suppression of tumour growth in vivo, after thermal neutron irradiation.

Animals↗

PubMed1999

Fragmentation of 200 and 244 MeV/u carbon beams in thick tissue-like absorbers.

Stacks consisting of thin CR-39 sheets sandwiched between thick lucite and water absorbers were perpendicularly bombarded by 12C ions at 200 and 244 MeV/u. Track radius distributions representing the charge composition of the fragmented beams were automatically measured by a particle track analysis system. After analysis of the nuclear charge distributions, the total charge removal cross-sections and elemental production cross-sections of fragments with atomic numbers from 5 to 3, were obtained down to the lower energies (approximately 50 and 100 MeV/u, respectively). It has been found that the measured total charge removal cross-section agrees with theoretical predictions within approximately 10% and very well with previous experiments in corresponding energy regions. Two model calculations for production of B fragment are in good agreement with our measured data while a third model overestimates it by approximately 12%. Theoretical cross-sections for Be and Li fragments differ strongly among the different models and from measured values.

Beryllium↗

PubMedDate not supplied

[Clinical study of administration of abciximab--a monoclonal antibody to platelet glycoprotein IIb/IIIa in percutaneous intracoronary interventions].

During the last 10 years a new group of drugs was developed--platelet glycoprotein IIb/IIIa blockers that is nowadays largely and efficiently used as for the prevention of percutaneous coronary intervention complications as well as in the treatment of acute coronary syndromes. In the period February-June 2000--19 patients (18 males, 1 female, of average age 53.3 years) were administered Abciximab in the bolus dose of 10 mg immediately before the intervention and afterwards 10 mg by 12-hour infusion. All patients received aspirin and ticlopidine hydrochloride if the stent was introduced and heparin by the standard protocol. Elective intervention was done in 17 patients (non-Q infarction in 3 patients, unstable angina pectoris in 5 patients, postinfarction angina pectoris in 2 patients, acute myocardial infarction at least 1 month before the intervention in 6 patients and 1 patient with myocardiopathy) and in 2 patients the intervention was performed during the myocardial infarction. In 15 patients (79%) intracoronary stent was introduced and in 5 patients (21%) the intervention was performed on 2 arteries. Maximal immediate effect of the dilatation was achieved in 18 patients (94.7%). In the first 60 days of the follow-up 1 patient (5%) died of some other disease, and in no patients symptomatic myocardial ischemia was found. No adverse effects were observed.

Abciximab↗

PubMedDate not supplied

Nucleolar volume in breast carcinomas.

The prognostic value of histopathological typing of breast carcinomas is relatively good. The determination of cell size has been a common and useful parameter in the diagnosis of various malignancies. With modern stereologic methods it is possible to obtain unbiased estimates of nucleolar volume. The aim of this study was to present our data regarding the nucleolar size in breast carcinoma. Patients treated for breast carcinoma (n = 39) were retrieved and randomly selected from the files of the University Institute of Pathology, Nis. Histological sections (4 microns) were cut from each of the routinely processed, paraffin-embedded tissue blocks and stained with hematoxylin and eosin. A Carl Zeiss NU-1 microscope equipped with a x 100 oil-immersion lens (N.A. = 1.25) and eyepiece graticule was used for stereological measurements. A total magnification of x 1600 was used. A simple grid was used for point sampling of nucleolar intercepts, which were measured in one arbitrary direction. By multiplying the averaged, cubed intercept length by pi/3, an unbiased estimate of volume-weighted nucleolar volume was obtained. The nucleolar volume was significantly larger in invasive ductal carcinoma (12.34 +/- 3.48 microns3) than invasive lobular carcinoma (5.6 +/- 2.73 microns 3) and mucinous (colloid) adenocarcinoma (0.88 +/- 0.42 micron 3). Various histological types of breast cancer exhibit differences with regard to nucleolar volume.

Adult↗